The importance of hormesis to public health

Ciencia e Saude Coletiva

Volumn 12, Issue 4, 2007, Pages 955-963

  Cook, Ralph ^a   Calabrese, Edward J ^b  

^a RRC Consulting   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Biphasic; Dose response; Environment; Hormesis; Risk assessment

Indexed keywords

EID: 34447260228     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/s1413-81232007000400017     Document Type: Review

References (59)

1. Academie Nationale de Medecine. 2005. Dose-Effect Relationships and Estimation of the Carcinogenic Effects of Low Doses of Ionizing Radiation. [accessed 2006 Aug 31]. Available from: http://www.academie-sciences.fr/ publications/rapports/pdf/ dose_effet_07_ 04_05_gb.pdf
2. Cedergreen N, Ritz C, Streibig JC. Improved empirical models describing hormesis. Environ Toxicol Chem 2005; 24:3166-3172.
3. Kaiser J. Hormesis: sipping from a poisoned chalice. Science 2003;302:376-379.
4. Puatanachokchai R, Morimura K, Wanibuchi H, Oka M, Kinoshita A, Mitsuru F, et al. Alpha-benzene hexachloride exerts hormesis in preneoplastic lesion formation of rat hepatocarcinogenesis with the possible role for hepatic detoxifying enzymes. Cancer Lett 2005; 240:102-113. [accessed 2005 Oct 24]. Available from: http://www.ehponline.org/members/2006/8606/8606.html
5. Randic M, Estrada E. Order from chaos: observing hormesis at the proteome level. J Proteome Res 2005; 4:2133-2136.
6. Renner R. Hormesis: Nietzsche's toxicology. Sci Am 2003; 289:28-30.
7. Thayer KA, Melnick R, Burns K, Davis D, Huff J. Fundamental flaws of hormesis for public health decisions. Environ Health Perspect 2005;113:1271-1276.
8. Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview . Toxicol Appl Pharmacol 2005; 202:289-301.
9. Brandes LJ. Hormetic effects of hormones, antihormones, and antidepressants on cancer cell growth in culture: in vivo correlates. Crit Rev Toxicol 2005; 35:587-592.
10. Celik I, Surucu O, Dietz C, Heymach JV, Force J, Hoschele I, et al. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res 2005; 65:11044-11050.
11. Chiueh CC, Andoh T, Chock PB. Induction of thioredoxin and mitochondria survival proteins mediates preconditioninginduced cardioprotection and neuroprotection. Ann New York Acad Sci 2005; 1042:403-418.
12. Lindsay DG. Nutrition, hormetic stress and health. Nutr Res Rev 2005;18:249-258.
13. Lamming DW, Wood JG, Sinclair DA. The importance of hormesis to public health that regulate lifespan: evidence for xenohormesis. Mol Microbiol 2004; 53:1003-1009.
14. Rattan SIS. Aging intervention, prevention, and therapy through hormesis. J Gerontol A Biol Sci Med Sci 2004; 59:705-709.
15. Rattan SIS. Hormetic mechanisms of anti-aging and rejuvenating effects of repeated mild heat stress on human fibroblasts in vitro. Rejuven Res 2004; 7:40-48.
16. Rattan SIS. Mechanisms of hormesis through mild heat stress on human cells. Ann New York Acad Sci 2004; 1019:554-558.
17. Rattan SIS. Anti-ageing, strategies: prevention or therapy? Slowing ageing from within. EMBO Rep 2005; 6:S25-S29.
18. Sinclair DA. Toward a unified theory of caloric restriction and longevity regulation. Mech Age Dev 2005; 126:987-1002.
19. Brandt K, Christensen LP, Hansen-Moller J, Hansen SL, Haraldsdottir J, Jespersen L, et al. Health promoting compounds in vegetables and fruits: a systematic approach for identifying plant components with impact on human health. Trends Food Sci Technol 2004; 15:384-393.
20. Shama G, Alderson P. UV hormesis in fruits: a concept ripe for commercialization. Trends Food Sci Technol 2005; 16:128-136.
21. Brugmann WB, Firmani MA. Low concentrations of nitric oxide exert a hormetic effect on Mycobacterium tuberculosis in vitro. J Clin Microbiol 2005; 43:4844-4846.
22. Dietert RR. Commentary on hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol 2005; 35:305-306.
23. Liu S-Z. Nonlinear dose-response relationships in the immune system following exposure to ionizing radiation: mechanisms and implications. Nonlinearity Biol Toxicol Med 2003; 1:71-92.
24. Stebbing ARD. Hormesis: interpreting the beta-curve using control theory. J Appl Toxicol 2000; 20:93-101.
25. Radak Z, Chung HY, Goto S. Exercise and hormesis: oxidative stress-related adaptation for successful aging. Biogerontology 2005; 6:71-75.
26. Fukushima S, Kinoshita A, Puatanachokchai R, Kushida M, Wanibuchi H, Morimura K. Hormesis and doseresponse-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens. Carcinogenesis 2005; 26:1835-1845.
27. Calabrese EJ. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ Pollut 2005; 138:379-411.
28. Calabrese EJ. Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol 2005; 51:643-654.
29. Axelrod D, Burns K, Davis D, von Larebeke N. "Hormesis"- an inappropriate extrapolation from the specific to the universal. Int J Occup Env Health 2004; 10:335-339.
30. Calabrese EJ. Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 2005; 35:463-582.
31. Calabrese EJ. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical implications. Crit Rev Toxicol 2005; 35:89-296.
32. Calabrese EJ, Baldwin LA. Agonist concentration gradients as a generalizable regulatory implementation strategy. Crit Rev Toxicol 2001; 31:471-474.
33. Levchenko A, Bruck J, Sternberg, PW. Regulatory modules that generate biphasic signal response in biological systems. Syst Biol 2004; 1:139-148.
34. Szabadi E. A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol 1977; 69:101-112.
35. Calabrese EJ, Baldwin LA. Hormesis: U-shaped doseresponse and their centrality in toxicology. Trends Pharmacol Sci 2001; 22(6):285-291.
36. Calabrese EJ, Baldwin LA. The hormesis model is more frequent than the threshold model in toxicology. Toxicol Sci 2003; 71:246-250.
37. Johnson BL. A most remarkable document for the US EPA. Hum Ecol Risk Assess 2004; 10:961-964.
38. Risk Assessment Task Force. An Examination of EPA Risk Assessment Principles and Practices. EPA/100/B-04/001. Washington, DC: U.S. Environmental Protection Agency; 2004. [accessed 2006 Sep 1]. Available from: http://www.epa.gov/osa/pdfs/ratf-final.pdf
39. Kathren RL. Pathway to a paradigm: the linear nonthreshold dose-response model in historical context. The American Academy of Health Physics 1995 Radiology Centennial Hartman Oration. Health Phys 1996; 70:621-635.
40. Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxicol 2002; 21:91-97.
41. Lin Y, Kikuchi S, Tamakoshi A, Wakai K, Kawamura T, Iso H, et al. Alcohol consumption and mortality among middleaged and elderly Japanese men and women. Ann Epidemiol 2005; 15:590-597.
42. Calabrese EJ. Prostaglandins: biphasic dose responses. Crit Rev Toxicol 2001; 31:475-488.
43. Calabrese EJ. Nitric oxide: biphasic dose responses. Crit Rev Toxicol 2001; 31:489-502.
44. Calabrese EJ. Estrogen and related compounds: biphasic dose responses. Crit Rev Toxicol 2001; 31:503-516.
45. Calabrese EJ. Androgens: biphasic dose responses. Crit Rev Toxicol 2001; 31:517-522.
46. Calabrese EJ. Adrenergic receptors: biphasic dose responses. Crit Rev Toxicol 2001; 31:523-538.
47. Calabrese EJ. Adenosine: biphasic dose responses. Crit Rev Toxicol 2001; 31:539-552.
48. Calabrese EJ. 5-Hydroxytryptamine (serotonin): biphasic dose responses. Crit Rev Toxicol 2001; 31:553-562.
49. Calabrese EJ. Dopamine: biphasic dose responses. Crit Rev Toxicol 2001; 31:563-584.
50. Calabrese EJ. Opiates: biphasic dose responses. Crit Rev Toxicol 2001; 31:585-604.
51. Gupta PK. The 2005 Nobel Prize in physiology or medicine: Helicobacter pylori and its role in gastritis and peptic ulcer disease. Curr Science 2005; 89:1651-1654.
52. Lave LB. Hormesis: implications for public policy regarding toxicants. Annu Rev Public Health 2001; 22:63-67.
53. Calabrese EJ, Baldwin LA. Hormesis and high-risk groups. Regul Toxicol Pharmacol 2002; 35:414-428.
54. Walsh G, Bahner LE, Horning W. Toxicity of textile mill effluents to freshwater and estuarine algae, crustaceans and fishes. Environ Pollut 1980; 21:169-179.
55. Laughlin RR Jr, Ng J, Guard HE. Hormesis: a response to low environmental concentrations of petroleum hydrocarbons. Science 1981; 211:705-707.
56. Flood JF, Smith GE, Cherkin A. Memory enhancement: supra-additive effect of subcutaneous cholinergic drug combinations in mice. Pyschopharmacology 1985; 86:61-67.
57. Gennings C, Carter WH Jr, Campain JA, Bae D-S, Yang RSH. Statistical analysis of interactive cytotoxicity in human epidermal keratinocytes following exposure to a mixture of four metals. J Agric Biol Environ Stat 2002; 7:58-73.
58. NRC (National Research Council). Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academies Press; 2005. [accessed 2005 Aug 18]. Available from: http://www.nap.edu/books/ 030909156X/html
59. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose-responses in the toxicological literature. Toxicol Sci 2001; 62:330-338.